Are peptides safe?
A vial of a popular weight-loss peptide bought online, labeled 99 percent pure, tested at less than 15 percent. That one result explains most of what you need to know about peptide safety.
Free to join · One email when peptide care opens · Most lab results in 3–5 business days
The answer, in short
Many peptides are safe enough to be approved medicines, including insulin and GLP-1 drugs. For the newer peptides people ask about, safety depends on three things. The molecule itself, which often has little human safety data. The product, since online vials have tested far below their labeled purity. And the person, whose history and labs decide what is sensible.
Medically reviewed by Robert Lufkin, MD (opens in a new tab)
Chief Medical Officer, Vitals Vault · Updated · 20 sources
The vial that tested at 14 percent
In a study published in 2024, a team of pharmacists in Hungary did what most buyers never do. They ordered semaglutide, the GLP-1 weight-loss peptide, from illegal online pharmacies that sold it without a prescription, and they ran the vials through a laboratory. Three of the six orders arrived. The three prefilled pens they also ordered never came, which tells you something about the sellers before anyone opens a box.
The vials that did arrive carried labels promising 99 percent purity. Measured purity ran from 7.7 to 14.4 percent. Every vial contained bacterial endotoxin, the fever-causing debris left behind by dead bacteria. Stranger still, the amount of semaglutide in each vial was higher than the label said, by roughly 29 to 39 percent. So the buyer got more drug than promised, mixed into a much larger amount of something else, and nobody could say what that something else was.
Keep that study in mind for the rest of this page. When people ask whether peptides are safe, they usually mean the molecule. Is BPC-157 safe, is MOTS-c safe, will this signal harm me. Those are fair questions. But for a peptide bought online, the molecule is often the smallest unknown in the vial.1
Peptide safety is three questions, asked in order
A peptide is a short chain of amino acids, the same building blocks as the protein on your plate. Your body runs on them. Insulin is a peptide. So are the hormones that tell you you are full, the signals that start ovulation and the molecules that ask the pituitary for growth hormone. Since insulin reached patients about a century ago, more than 80 peptide drugs have come to market for diabetes, cancer, osteoporosis, HIV and pain.
As a class, peptides have a good reputation with drug developers. They tend to be highly selective, hitting one receptor rather than several, and they are generally well tolerated. Most are cut apart by enzymes into amino acids your body already knows how to use. BPC-157, for example, has a half-life in blood of under 30 minutes.
None of that makes any single peptide safe by default. A well-behaved family can still contain a molecule that pushes a hormone too hard, or one that simply has never been tested in people. So it helps to break the question into three parts and ask them in order.2316
- 01
The molecule
What does this peptide do in the body, and how much human safety data exists? For some peptides the answer is years of phase 3 trials. For others it is a handful of small studies or none at all.317
- 02
The product
Is the vial what it says it is? Identity, purity, sterility and dose are separate questions from the science of the molecule, and they are where online products fail most often.14
- 03
The person
Who is taking it, with what history and what baseline labs? The same peptide can be a reasonable choice for one adult and a poor one for someone with a cancer history, diabetes or a pregnancy.1416
Approved, compounded and research peptides are three different products
The word peptide covers products with very different safety paperwork behind them. An approved peptide medicine has been through controlled trials for a specific use, and the finished product is made under drug manufacturing rules. Bremelanotide, studied for low sexual desire in women, followed that path to approval in 2019, and its trials and long-term extension are published.
A compounded peptide is prepared by a licensed pharmacy for one named patient, on a prescription. Under section 503A of federal law, the pharmacy works from bulk ingredients and follows pharmacy standards. The finished preparation is not reviewed as a drug product the way an approved medicine is, but there is a prescriber, a pharmacist and a paper trail, and the pharmacy answers to a state board.
A research peptide, sold online as "for research use only", is a chemical sold for laboratory work. It is not made for people, and no one checks it before it reaches you. That is the category the Hungarian semaglutide vials belonged to in practice, and it is where most of the documented quality failures sit.
| Attribute | Approved medicine | Compounded (503A) | Research use only |
|---|---|---|---|
| Who makes it | Drug manufacturer | Licensed compounding pharmacy | Chemical supplier |
| Prescription | Yes | Yes, for one named patient | No |
| Product tested before you get it | Yes, to approved specifications | Pharmacy standards apply | No requirement |
| Human safety data | Phase 3 trials | Depends on the peptide | Depends on the peptide |
| Made for people | Yes | Yes | No |
What goes wrong in the vial
The semaglutide study is not a one-off. Anti-doping scientists tested 17 black-market products sold as follistatin-344, a protein studied for muscle growth. Only 9 of them contained follistatin at all. The others were mislabeled or held different peptides. If you are injecting a product to change a growth signal, finding out that half the market is mislabeled is unsettling.
Even supplies meant for scientists can surprise the scientists. A University of Illinois group ran two custom peptides they had bought for research through nuclear magnetic resonance, a technique that sees molecules the usual quality test can miss. One peptide was 20 percent mannitol by weight, the other 43 percent. Mannitol is a sugar alcohol, harmless in itself, but it was not on the label, and the usual chromatography test can be blind to it. The authors concluded that measurement has to replace trust, even in research-grade chemicals.
For an injected product, sterility matters as much as identity. Endotoxin, the bacterial debris found in every one of the Hungarian vials, can cause fever, chills and a drop in blood pressure. A product can be free of living bacteria and still carry it. FDA’s compounding safety page lists peptide-related impurities among its concerns for several peptides that were nominated for compounding and later withdrawn.45117
Immune reactions, and why impurities matter most
Your immune system is built to notice unfamiliar chains of amino acids, because that is what most viruses and bacteria look like from the inside. A peptide copied exactly from a human sequence usually passes as self. A slightly wrong copy may not.
Peptide synthesis produces near-miss molecules as a matter of course. A chain can come out missing one amino acid, carrying an extra one or bearing a chemical scar from the manufacturing steps. Immunologists at EpiVax, working on how FDA should judge generic peptide drugs, describe how such impurities can create new T-cell epitopes, the short stretches the immune system learns to attack. If that happens, the body may make antibodies against the peptide, which can blunt its effect or, more rarely, cause an allergic reaction.
This is measurable. In a 2025 case study run with FDA scientists, the team tested teriparatide, an approved bone-building peptide, alongside impurities found in generic versions. Several impurities were more immunogenic than the drug itself in laboratory tests, while teriparatide carried a sequence that seemed to calm the immune response. FDA raised possible immunogenicity in its notes on AOD-9604, a fat-loss peptide, when it was nominated for compounding.6717
When the molecule itself is the risk
Purity solves a lot, but not everything. Some peptides carry risks that come straight from what they do. Melanotan II is the clearest example. It switches on melanocortin receptors to darken skin, and people who bought it to tan have turned up in case reports with new and changing moles, melanoma, prolonged painful erections and muscle breakdown.
Growth hormone signals deserve a quieter kind of caution. MK-677, an oral compound that acts on the same receptor as the growth hormone peptides, raised IGF-1 in older adults for a year, but fasting glucose rose and insulin sensitivity fell. In obese men, two months of it worsened glucose tolerance. These are the changes a blood test catches long before you would feel them.
Then there is the large group of peptides with almost no human safety data at all. A 2025 systematic review of BPC-157 in sports medicine found 36 studies, and 35 were in animals or cells. Reviews report few adverse reactions, but formal human safety trials have not been published, and FDA’s April 2026 compounding page said it had limited safety information for the proposed routes. That is an absence of evidence, which is different from evidence of harm and also different from evidence of safety.1011121314151617
Who should be most careful
Several of the most popular peptides work by encouraging growth. BPC-157 builds new blood vessels. Growth hormone peptides raise IGF-1, a signal that tells cells to divide. That is the point when the goal is a healing tendon, and a concern when someone has a personal history of cancer. Anyone in that situation should talk it through with a clinician before starting.
Pregnancy and breastfeeding are a firm pause, since none of these newer peptides has been studied there. People with diabetes or prediabetes should know that growth hormone peptides can push blood sugar up. People with kidney or liver disease clear peptides differently. And tested athletes face a separate rule, because the World Anti-Doping Agency prohibits many of these peptides in and out of competition.
The safest pattern we know of looks the same across all of them. A health history, baseline labs, a defined course with a reason to stop, and a retest that shows whether anything moved in the wrong direction.161420
- 01
Liver and kidney markers
ALT and eGFR before a course give a clinician a reference point if anything changes.
- 02
Blood sugar
HbA1c and fasting glucose matter most for growth hormone peptides, which can raise both.14
- 03
Inflammation
An unexpected rise in hs-CRP after starting an injected product is a reason to stop and ask questions.
Where regulation stands
Since October 29, 2026, FDA allows 503A pharmacies to compound six peptides, BPC-157, TB-500, epitalon, KPV, MOTS-c and Semax, for individual patients with a prescription, under enforcement discretion while final rulemaking is pending. None of the six is FDA-approved. Research-use vials are not covered by the policy.1918
What it means for you
Is a given peptide safe? Start with the vial, because that is the question you can actually answer. A prescription filled by a licensed pharmacy removes the largest and most avoidable risk on this page, the one where the label says 99 percent and the lab says 14.
Then look honestly at the molecule. Some peptides have phase 3 trials behind them. Many have a few small studies. Several have only animal data. None of those is a reason for panic, and none is a reason for confidence. They are a reason to go in with a plan.
Finally, bring your own numbers. A baseline panel turns a vague worry into something you can track, and a retest tells you whether your body agrees with the theory. The question worth asking a clinician is simple. Given my history and these labs, what would make you tell me to stop?116
Start with your labs
A blood test before you start and a retest after shows what actually changed for you. It is how Vitals Vault approaches every treatment.
- TestA baseline panel at Quest Diagnostics.
- DecideA licensed clinician reviews your history and results.
- RetestThe same markers again, side by side.
- Liver enzymes (ALT)Part of a metabolic panel. Checks the liver before and during any new prescription.
- Kidney function (eGFR)Peptides are cleared through the kidneys, so a baseline is useful.
- HbA1cYour average blood sugar over about three months.
- hs-CRPA blood marker of inflammation you can track before and after a course.
Questions
Are peptides safe?
Many peptides are approved medicines with well-known safety profiles, such as insulin and GLP-1 drugs. Newer peptides like BPC-157 have little human safety data. The biggest avoidable risk is product quality, since online vials have tested far below their labeled purity.
What are the side effects of peptides?
They depend on the peptide. Injection-site reactions are common across the class. Growth hormone peptides can raise blood sugar. Melanotan II has been linked to new moles, melanoma and prolonged erections in case reports. Contaminated products add fever and infection risk.
Are research peptides safe to inject?
Products labeled "for research use only" are not made for people and are not checked before sale. Studies of black-market products have found wrong ingredients, low purity and bacterial endotoxin. A prescription filled by a licensed pharmacy avoids those risks.
Can peptides cause an immune reaction?
They can. Impurities created during manufacturing may form new targets for the immune system, which can lead to antibodies against the peptide. In a 2025 study, several impurities of an approved peptide were more immunogenic than the drug itself.
Are compounded peptides safer than research peptides?
Compounded peptides come from a licensed pharmacy, are made for a named patient on a prescription and follow pharmacy standards. Research peptides have no such checks. Compounding does not make an untested molecule proven, but it does address purity and sterility.
Who should avoid peptides?
Anyone pregnant or breastfeeding, and tested athletes for prohibited peptides. People with a cancer history, diabetes, or kidney or liver disease should talk to a clinician first, since some peptides raise growth signals or blood sugar.
Do peptides damage the liver or kidneys?
Most peptides break down into amino acids and are cleared through the liver and kidneys. Serious organ harm is uncommon in published studies, but human data are thin for many peptides. Baseline ALT and eGFR give you a reference point.
Are peptides steroids?
No. Steroids are built on a four-ring fat-based structure. Peptides are short chains of amino acids, a different class of molecule with different effects and risks.
Peptides, prescribed and measured
Vitals Vault is opening peptide care that starts with your blood work, is prescribed by licensed US clinicians and ends with a retest. Join the waitlist to hear first.
- Prescription only
- Licensed US clinicians
- Quest Diagnostics labs
Keep reading
Full Peptide Guide- BPC-157A 15-amino-acid peptide from a stomach protein, studied for tendon, muscle and gut repair.
- Melanotan IIA synthetic melanocortin peptide that darkens skin and affects sexual function. Unapproved, with documented safety reports.
- Follistatin-344A muscle-regulating protein that binds myostatin. Strong in animals. Human FS344 data come from gene therapy, not injected protein.
- MK-677An oral, non-peptide ghrelin-receptor agonist that raises growth hormone and IGF-1. FDA lists a heart failure concern.
- How are peptides made?From pig pancreas to bacteria to resin beads: the three ways peptides are made, and why purity is earned at the end.
- FDA peptide update 2026What FDA’s October 2026 decision on six peptides means for you.
Sources
- 1. Ashraf AR, et al. Multifactor quality and safety analysis of semaglutide products sold by online sellers without a prescription. J Med Internet Res. 2024 (opens in a new tab)
- 2. Muttenthaler M, et al. Trends in peptide drug discovery. Nat Rev Drug Discov. 2021 (opens in a new tab)
- 3. Fosgerau K, Hoffmann T. Peptide therapeutics: current status and future directions. Drug Discov Today. 2015 (opens in a new tab)
- 4. Reichel C, et al. Detection of black market follistatin 344. Drug Test Anal. 2019 (opens in a new tab)
- 5. Choules MP, et al. NMR reveals an undeclared constituent in custom synthetic peptides. J Pharm Biomed Anal. 2020 (opens in a new tab)
- 6. De Groot AS, et al. Immunogenicity risk assessment of synthetic peptide drugs and their impurities. Drug Discov Today. 2023 (opens in a new tab)
- 7. Mattei AE, et al. Immunogenicity risk assessment of peptide-related impurities identified in generic teriparatide products. Front Immunol. 2025 (opens in a new tab)
- 8. Dhillon S, Keam SJ. Bremelanotide: First Approval. Drugs. 2019 (opens in a new tab)
- 9. Simon JA, et al. Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder. Obstet Gynecol. 2019 (opens in a new tab)
- 10. Hjuler KF, et al. Melanoma associated with the use of melanotan-II. Dermatology. 2014 (opens in a new tab)
- 11. Cousen P, et al. Eruptive melanocytic naevi following melanotan injection. Br J Dermatol. 2009 (opens in a new tab)
- 12. Mallory CW, et al. Melanotan Tanning Injection: A Rare Cause of Priapism. Sex Med. 2021 (opens in a new tab)
- 13. Nelson ME, et al. Melanotan II injection resulting in systemic toxicity and rhabdomyolysis. Clin Toxicol (Phila). 2012 (opens in a new tab)
- 14. Nass R, et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Ann Intern Med. 2008 (opens in a new tab)
- 15. Svensson J, et al. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure. J Clin Endocrinol Metab. 1998 (opens in a new tab)
- 16. Vasireddi N, et al. Emerging use of BPC-157 in orthopaedic sports medicine: a systematic review. HSS J. 2025 (opens in a new tab)
- 17. FDA. Certain bulk drug substances for use in compounding that may present significant safety risks (current as of April 22, 2026) (opens in a new tab)
- 18. FDA. Bulk drug substances used in compounding under section 503A (opens in a new tab)
- 19. NCPA. FDA grants enforcement discretion for compounding six peptides. October 29, 2026 (opens in a new tab)
- 20. World Anti-Doping Agency. Prohibited List (opens in a new tab)